GB-Harwell: UKRI-3528 Rare Disease Portfolio Valuation Consultancy

Competitive Contract Award Notice

1. Title: GB-Harwell: UKRI-3528 Rare Disease Portfolio Valuation Consultancy
2. Awarding Authority:
UK Research & Innovation
Polaris House, North Star Avenue, Swindon, SN2 1FL, United Kingdom
Tel. +44 1793867000, Email:, URL:
Contact: MRC Procurement, Attn: MRC Procurement
3. Contract Type: Services
Sub Type: Other services.

4. Description: Research consultancy services. Financial consultancy services. Evaluation consultancy services. Rare Disease Portfolio Valuation Consultancy
5. CPV Codes:
73210000 - Research consultancy services.
66171000 - Financial consultancy services.
79419000 - Evaluation consultancy services.

6. NUTS Codes :
UKJ14 - Oxfordshire

7. Main Site or Location of Works, Main Place of Delivery or Main Place of Performance: Oxfordshire,
8. Reference Attributed by the Awarding Authority: UKRI-3528
9. Awarded to:

PharmaVentures Ltd
National ID: 03419584, Oxford House, Oxford Business Park South, Oxford, OX4 2JY, United Kingdom
Tel. +44 (0) 1865 332 700
Contact: Sales, Attn: Sales
Value Cost: 25,000
Is Awardee likely to subcontract?: No Awarded to SME?: Yes
10. Date of Contract Award: 21/12/2023
11. Number of Tenders Received: Not Provided
12. Other Information:
Other Information: Procurement Contract Transparency Data: Redacted contract documents will be made available within the next 30 days on the UKRI website at:
To view this notice, please click here:
Suitable for VCO: No
Period of Work Start date: 22/12/2023
Period of Work End date: 23/12/2023